Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1390611

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1390611

Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Abstract

The global hormonal contraceptive market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.9 Billion by 2028, exhibiting a growth rate (CAGR) of 4.19% during 2022-2028.

Hormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.

Hormonal Contraceptive Market Trends:

The global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, hormone, age group and end user.

Breakup by Product:

Oral Contraceptive Pills

Intrauterine Device (IUD)

Injectable Birth Control

Vaginal Rings

Others

Breakup by Hormone:

Progestin-only Contraceptive

Combined Hormonal Contraceptive

Breakup by Age Group:

15-24 Years

25-34 Years

35-44 Years

Above 44 Years

Breakup by End User:

Hospitals and Clinics

Homecare

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

  • How has the global hormonal contraceptive market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hormonal contraceptive market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the hormone?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hormonal contraceptive market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112023A4403

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormonal Contraceptive Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oral Contraceptive Pills
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intrauterine Device (IUD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Injectable Birth Control
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Vaginal Rings
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Hormone

  • 7.1 Progestin-only Contraceptive
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Combined Hormonal Contraceptive
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 15-24 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 25-34 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 35-44 Years
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Above 44 Years
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Homecare
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Afaxys Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agile Therapeutics Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Allergan Inc. (AbbVie Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Bayer AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Cipla Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Piramal Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Teva Pharmaceutical Industries Ltd
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
Product Code: SR112023A4403

List of Figures

  • Figure 1: Global: Hormonal Contraceptive Market: Major Drivers and Challenges
  • Figure 2: Global: Hormonal Contraceptive Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Hormonal Contraceptive Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Hormonal Contraceptive Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Hormonal Contraceptive Market: Breakup by Hormone (in %), 2022
  • Figure 6: Global: Hormonal Contraceptive Market: Breakup by Age Group (in %), 2022
  • Figure 7: Global: Hormonal Contraceptive Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Hormonal Contraceptive Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Hormonal Contraceptive (Injectable Birth Control) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Hormonal Contraceptive (Injectable Birth Control) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Hormonal Contraceptive (Vaginal Rings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Hormonal Contraceptive (Vaginal Rings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Hormonal Contraceptive (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Hormonal Contraceptive (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Hormonal Contraceptive (15-24 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Hormonal Contraceptive (15-24 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Hormonal Contraceptive (25-34 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Hormonal Contraceptive (25-34 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Hormonal Contraceptive (35-44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Hormonal Contraceptive (35-44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Hormonal Contraceptive (Above 44 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Hormonal Contraceptive (Above 44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Hormonal Contraceptive (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Hormonal Contraceptive (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Hormonal Contraceptive (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Hormonal Contraceptive (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Hormonal Contraceptive (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Hormonal Contraceptive (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Hormonal Contraceptive Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Hormonal Contraceptive Industry: SWOT Analysis
  • Figure 89: Global: Hormonal Contraceptive Industry: Value Chain Analysis
  • Figure 90: Global: Hormonal Contraceptive Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hormonal Contraceptive Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Hormonal Contraceptive Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Hormonal Contraceptive Market Forecast: Breakup by Hormone (in Million US$), 2023-2028
  • Table 4: Global: Hormonal Contraceptive Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
  • Table 5: Global: Hormonal Contraceptive Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Hormonal Contraceptive Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Hormonal Contraceptive Market: Competitive Structure
  • Table 8: Global: Hormonal Contraceptive Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!